An European Organisation for Research and Treatment of Cancer phase I study of lapatinib and docetaxel as neoadjuvant treatment for Human Epidermal Growth Factor Receptor 2 (HER2) positive locally-advanced/inflammatory or large operable breast cancer
Titel:
An European Organisation for Research and Treatment of Cancer phase I study of lapatinib and docetaxel as neoadjuvant treatment for Human Epidermal Growth Factor Receptor 2 (HER2) positive locally-advanced/inflammatory or large operable breast cancer
Auteur:
Bonnefoi, H. Zaman, K. Debled, M. Fiche, M. Fournier, M. Nobahar, M. Pierga, J-Y Koch, K.M. Bartlett, J. Zimmer, A. Marreaud, S. Bogaerts, J. Cameron, D.